Table 2 Overall and disease-free survival of the study population by family history and tumor stage
TMN | Family history | n | Overall survival | ||||
|---|---|---|---|---|---|---|---|
Median survival (months) | 1 year (%) | 3 years (%) | 5 years (%) | P value | |||
All | Positive | 169 | 43 | 79.3 | 54.7 | 43.5 | 0.511 |
Negative | 1,144 | 47 | 79.2 | 55.5 | 45.8 | ||
I | Positive | 87 | 79 | 87.4 | 71.0 | 58.9 | 0.282 |
Negative | 623 | 123 | 89.7 | 71.0 | 58.9 | ||
II | Positive | 21 | 32 | 81.0 | 44.2 | 36.8 | 0.441 |
Negative | 146 | 53 | 75.3 | 55.9 | 48.6 | ||
III | Positive | 61 | 22 | 67.7 | 34.7 | 24.8 | 0.550 |
Negative | 375 | 20 | 63.2 | 29.9 | 23.0 | ||
TMN | Family history | n | Disease-free survival | ||||
Median survival (month) | 1 year (%) | 3 years (%) | 5 years (%) | P value | |||
All | Positive | 169 | 12 | 50.3 | 33.8 | 27.6 | 0.231 |
Negative | 1,144 | 14 | 52.9 | 36.7 | 32.4 | ||
I | Positive | 87 | 28 | 61.2 | 45.6 | 36.4 | 0.186 |
Negative | 623 | 35 | 66.8 | 49.2 | 44.5 | ||
II | Positive | 21 | 4 | 40.9 | 29.8 | 29.8 | 0.202 |
Negative | 146 | 12 | 49.0 | 35.8 | 32.2 | ||
III | Positive | 61 | 7 | 38.7 | 18.7 | 15.0 | 0.337 |
Negative | 375 | 5 | 31.5 | 16.2 | 12.2 | ||